Acod1 expression in cancer cells promotes immune evasion through the generation of inhibitory peptides

[1]  Xuemin Lu,et al.  Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1. , 2023, Cell metabolism.

[2]  Xuemin Lu,et al.  Overcome Prostate Cancer Resistance to Immune Checkpoint Therapy with Ketogenic Diet-Induced Epigenetic Reprogramming , 2023, bioRxiv.

[3]  Y. Xiong,et al.  Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy , 2023, Science advances.

[4]  Stacy L. Gelhaus,et al.  Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment , 2023, Cell.

[5]  Y. Xiong,et al.  The immunometabolite itaconate stimulates OXGR1 to promote mucociliary clearance during the pulmonary innate immune response , 2023, The Journal of clinical investigation.

[6]  T. Atsumi,et al.  Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming , 2023, Nature Communications.

[7]  J. Taube,et al.  Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  A. Prince,et al.  Staphylococcus aureus stimulates neutrophil itaconate production that suppresses the oxidative burst , 2023, Cell reports.

[9]  K. Flaherty,et al.  Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth. , 2022, Nature metabolism.

[10]  E. Ma,et al.  Carbon source availability drives nutrient utilization in CD8+ T cells , 2022, Cell metabolism.

[11]  Y. Zeng,et al.  Itaconate is a lysosomal inducer that promotes antibacterial innate immunity. , 2022, Molecular cell.

[12]  Su-Jeong Kim,et al.  Mitochondria-derived peptides in aging and healthspan , 2022, The Journal of clinical investigation.

[13]  K. Büssow,et al.  Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism , 2022, Nature Metabolism.

[14]  Christian M. Metallo,et al.  Mesaconate is synthesized from itaconate and exerts immunomodulatory effects in macrophages , 2022, Nature Metabolism.

[15]  R. Zappasodi,et al.  A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance , 2022, Nature Immunology.

[16]  Xin Hu,et al.  The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer. , 2022, Cell metabolism.

[17]  Yanling Zhang,et al.  Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages. , 2022, Cell metabolism.

[18]  D. Tang,et al.  Mitochondrial ACOD1/IRG1 in infection and sterile inflammation , 2022, Journal of intensive medicine.

[19]  Trevor J Pugh,et al.  Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. , 2022, Immunity.

[20]  E. Boccardo,et al.  Metabolic Reprogramming and Cancer , 2021, Essential Aspects of Immunometabolism in Health and Disease.

[21]  B. Helmink,et al.  Hallmarks of response, resistance, and toxicity to immune checkpoint blockade , 2021, Cell.

[22]  I. Keklikoglou,et al.  Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models , 2021, Science Translational Medicine.

[23]  Greg M. Delgoffe,et al.  Metabolic barriers to cancer immunotherapy , 2021, Nature Reviews Immunology.

[24]  Maxim N. Artyomov,et al.  Itaconate confers tolerance to late NLRP3 inflammasome activation , 2021, Cell reports.

[25]  Christian M. Metallo,et al.  Itaconate Alters Succinate and Coenzyme A Metabolism via Inhibition of Mitochondrial Complex II and Methylmalonyl-CoA Mutase , 2021, Metabolites.

[26]  T. Litman,et al.  Inhibition of succinate dehydrogenase activity impairs human T cell activation and function , 2021, Scientific Reports.

[27]  Elham Mousavinezhad Sarasia,et al.  A Global Review on Short Peptides: Frontiers and Perspectives , 2021, Molecules.

[28]  D. Tang,et al.  ACOD1 in immunometabolism and disease , 2020, Cellular & Molecular Immunology.

[29]  D. M. Simons,et al.  Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages , 2020, Nature metabolism.

[30]  B. Faubert,et al.  Metabolic reprogramming and cancer progression , 2020, Science.

[31]  Z. Schafer,et al.  Mitochondrial ROS and Mitophagy: A Complex and Nuanced Relationship. , 2020, Antioxidants & redox signaling.

[32]  Gary Siuzdak,et al.  METLIN: A Tandem Mass Spectral Library of Standards. , 2020, Methods in molecular biology.

[33]  A. Regev,et al.  Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma , 2019, Nature Medicine.

[34]  Takla Griss,et al.  Metabolic Profiling Using Stable Isotope Tracing Reveals Distinct Patterns of Glucose Utilization by Physiologically Activated CD8+ T Cells. , 2019, Immunity.

[35]  T. Honjo,et al.  Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy , 2019, bioRxiv.

[36]  E. V. Van Allen,et al.  Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients? , 2019, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[37]  Maxim N. Artyomov,et al.  Itaconate: the poster child of metabolic reprogramming in macrophage function , 2019, Nature Reviews Immunology.

[38]  Julia B. Cordero,et al.  The antimicrobial peptide defensin cooperates with tumour necrosis factor to drive tumour cell death in Drosophila , 2019, bioRxiv.

[39]  J. Locasale,et al.  The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons , 2019, Immunity.

[40]  J. Schneider,et al.  Itaconic acid indicates cellular but not systemic immune system activation , 2018, Oncotarget.

[41]  L. Emens,et al.  Targeting adenosine for cancer immunotherapy , 2018, Journal of Immunotherapy for Cancer.

[42]  Z. Schafer,et al.  RIPK1-dependent mitophagy: A novel mechanism to eliminate cells detached from the extracellular matrix , 2018, Molecular & cellular oncology.

[43]  John Szpyt,et al.  Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1 , 2018, Nature.

[44]  W. M. Leevy,et al.  RIPK1-mediated induction of mitophagy compromises the viability of extracellular-matrix-detached cells , 2018, Nature Cell Biology.

[45]  A. Iyer,et al.  PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome , 2017, Front. Pharmacol..

[46]  J. A. Mason,et al.  Metabolism during ECM Detachment: Achilles Heel of Cancer Cells? , 2017, Trends in cancer.

[47]  R. DePinho,et al.  Effective Combinatorial Immunotherapy for Castration Resistant Prostate Cancer , 2017, Nature.

[48]  Maxim N. Artyomov,et al.  Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation. , 2016, Cell metabolism.

[49]  Erguang Li,et al.  Suppression of IRG-1 Reduces Inflammatory Cell Infiltration and Lung Injury in Respiratory Syncytial Virus Infection by Reducing Production of Reactive Oxygen Species , 2016, Journal of Virology.

[50]  Jedd D. Wolchok,et al.  The future of cancer treatment: immunomodulation, CARs and combination immunotherapy , 2016, Nature Reviews Clinical Oncology.

[51]  C. Buchheit,et al.  Oncogenic Ras differentially regulates metabolism and anoikis in extracellular matrix-detached cells , 2016, Cell Death and Differentiation.

[52]  C. Rudin,et al.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. , 2015, The New England journal of medicine.

[53]  Dirk Schadendorf,et al.  Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. , 2015, The New England journal of medicine.

[54]  J. Lunceford,et al.  Pembrolizumab for the treatment of non-small-cell lung cancer. , 2015, The New England journal of medicine.

[55]  R. Emerson,et al.  PD-1 blockade induces responses by inhibiting adaptive immune resistance , 2014, Nature.

[56]  C. Buchheit,et al.  Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression , 2014, Nature Reviews Cancer.

[57]  F. Klawonn,et al.  Infection- and procedure-dependent effects on pulmonary gene expression in the early phase of influenza A virus infection in mice , 2013, BMC Microbiology.

[58]  J. Debnath,et al.  IκB kinase complex (IKK) triggers detachment-induced autophagy in mammary epithelial cells independently of the PI3K-AKT-MTORC1 pathway , 2013, Autophagy.

[59]  R. Balling,et al.  Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production , 2013, Proceedings of the National Academy of Sciences.

[60]  David C. Smith,et al.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.

[61]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[62]  Wenyun Lu,et al.  Itaconic acid is a mammalian metabolite induced during macrophage activation. , 2011, Journal of the American Chemical Society.

[63]  K. Pfeffer,et al.  The proinflammatory cytokine-induced IRG1 protein associates with mitochondria. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[64]  J. Welsh,et al.  Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[65]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[66]  D. Nicholson,et al.  Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B , 1995, Nature.

[67]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[68]  Hollis G. Potter,et al.  Author Manuscript , 2013 .